DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
批准号:
2700458
负责人:
CRAIG ARTHUR TOWNSEND
金额:
$24.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-10 至 2000-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Calicheamicin gamma1I (CLM), the neocarzinostatin chromophore,
esperamicin A1, dynemicin, kedarcidin, c-1027 and maduropeptin are
members of the structurally unprecedented and growing family of diynene
antitumor antibiotics. Reductive activation by thiols and/or simple
thermal rearrangement generates diradical species by an
electrocyclization process that is characteristic of this class. When
bound in the minor groove of DNA these radicals initiate helix cleavage
by hydrogen abstraction from one or both strands. The resulting DNA
radicals react with molecular oxygen and fragmentation ensues. While
single-strand breaks are typically the major cleavage event observed, CLM
is both notably sequence-selective and very largely a double-strand
cutter. Using a diverse array of experiments outlined in this renewal
proposal we seek to understand the origins of these properties and how
CLM can be used as a probe of protein/nucleic acid structure and in the
design of useful tools in molecular biology. The presumed lethality of
DNA damage, the induction of apoptosis and the demonstrated cytotoxicity
and cell cycle effects of these compounds have animated hope that,
through preferential uptake or selective delivery to cancer cells,
effective therapies might be possible. Clinical trials testing the latter
principle are underway.
Investigation of the low kinetic isotope effects associated with CLM-
induced hydrogen abstraction from DNA and the apparent absence of
isotope-induced branching will be completed. Whether these two events
occur in a simultaneous or stepwise manner will be distinguished. The
unusual behavior of A-tracts will be examined for kinetic acceleration
as a function of minor groove narrowing. The efficiencies of hydrogen
abstraction will be monitored and the distribution of cuts in the
cleavage cascade will be evaluated as a function of temperature. The
interaction of CLM with supercoiled plasmid DNA will be investigated as
a function of inserted A/T-rich segments causing varying degrees of
curvature. Extensive experiments are planned with nucleosomes to study
the occurrence of "hot spots" to understand whether CLM cleavage is
associated with physical location in the nucleosome or features of
particular DNA sequences. Automated methods will be used to evaluate
large amounts of data generated in mixed sequence nucleosomes. A
degradation product of CLM having essentially no sequence selectivity but
retaining double-strand cutting properties will be linked to homeodomains
to achieve specific binding for high efficiency cleavage of DNA. Success
in this effort will be evaluated in tests with DNA sequences already in
hand and will lay the groundwork for eventual experiments to be
undertaken for gene identification e.g. in Drosophila. Finally, CLM
reaction with transfer-, ribosomal- and messenger-RNA will be
investigated. In eukaryotic cells, RNA is a more accessible target than
DNA. These experiments will monitor the susceptibility of RNA to reaction
with CLM and particularly with rRNA in the ribosome for comparison to
nucleosomes and chromatin.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Hydroxyl radical footprinting of calicheamicin. Relationship of DNA binding to cleavage.
加利车霉素的羟基自由基足迹。
DOI:
10.1021/bi00168a029
发表时间:
1994
期刊:
Biochemistry
影响因子:
2.9
作者:
[Mah,SC, Townsend,CA, Tullius,TD]
通讯作者:
Tullius,TD
Biosynthesis of Beta Lactam Antibiotics
-
批准号:10295587
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2016
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
Biosynthesis of Beta Lactam Antibiotics
-
批准号:10406371
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2016
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
Biosynthesis of Beta Lactam Antibiotics
-
批准号:10601097
-
项目类别:
-
资助金额:$61.94万
-
财政年份:2016
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
400 MHZ NMR SPECTROMETER FOR SHARED USE: CHEMISTRY
-
批准号:6973212
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2004
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
400 MHz NMR Spectrometer for Shared Use
-
批准号:6735938
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2004
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
FINNIGAN LCQ ELECTROSPRAY MASS SPECTROMETER
-
批准号:6052089
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2000
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2095928
-
项目类别:
-
资助金额:$16.92万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
500 MHZ NMR INSTRUMENTATION FOR SHARED USE
-
批准号:3521167
-
项目类别:
-
资助金额:$40.0万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2414220
-
项目类别:
-
资助金额:$17.04万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:3198981
-
项目类别:
-
资助金额:$16.86万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:3198979
-
项目类别:
-
资助金额:$17.56万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:3198980
-
项目类别:
-
资助金额:$16.75万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2095929
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
DIYNENE ANTIBIOTICS AND THEIR DNA CLEAVAGE CHEMISTRY
-
批准号:2095930
-
项目类别:
-
资助金额:$26.38万
-
财政年份:1991
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
300 MHZ NMR INSTRUMENTATION FOR SHARED USE
-
批准号:3520276
-
项目类别:
-
资助金额:$27.5万
-
财政年份:1989
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
KRATOS MS-80 MASS SPECTROMETER
-
批准号:3519110
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1985
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
BIOSYNTHESIS OF AFLATOXIN
-
批准号:2153065
-
项目类别:
-
资助金额:$23.24万
-
财政年份:1978
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
BIOSYNTHESIS OF AFLATOXIN
-
批准号:2153066
-
项目类别:
-
资助金额:$24.25万
-
财政年份:1978
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
BIOSYNTHESIS OF AFLATOXIN
-
批准号:2153064
-
项目类别:
-
资助金额:$22.48万
-
财政年份:1978
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
BIOSYNTHESIS OF BETA LACTAM ANTIBIOTICS
-
批准号:2671695
-
项目类别:
-
资助金额:$31.98万
-
财政年份:1978
-
负责人:CRAIG ARTHUR TOWNSEND
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
基于异质人群多源数据识别单细胞 RNA数量性状风险位点的统计学方法研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡铭轩
-
依托单位:
uN2CpolyG蛋白经ALYREF蛋白介导RNA转运异常在神经元核内包涵体病发病中的作用及机制研究
-
批准号:2026JJ60587
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张思哲
-
依托单位:
病毒非编码RNA多样性图谱构建及其生物发生与致病机制研究
-
批准号:2026JJ60389
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:傅萍
-
依托单位:
核糖核酸酶RNase E与其抑制因子RebA通过液-液相分离调控蓝藻RNA代谢的分子机制
-
批准号:JCZRQNB202600879
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: